© 2021 MJH Life Sciences™ and Opthalmology Times Europe. All rights reserved.
Inflammation & Infection
Endophthalmitis most often caused by Staphylococcus
April 17, 2014
Endophthalmitis is most often caused by coagulase-negative Staphylococcus, and the antibiotics vancomycin and ceftazidime seem to perform well in treating it. That was one of the findings of a 25-year retrospective study conducted by Dr Ronald C. Gentile, of the New York Eye and Ear Infirmary, and his colleagues in New York City and San Antonio, Texas, USA.
Higher temperatures linked to severity of allergic conjunctivitis
March 14, 2014
Temperatures measured by a newly developed non-contact ocular surface thermographer (OST) can be used to evaluate the efficacy of topical anti-allergic agents because of the significant correlation of the conjunctival surface temperature and the severity of conjunctival allergic reaction, according to recently published data.
Private versus public healthcare: Is there an increased infection risk?
March 01, 2014
In this article, Dr Solborg Bjerrum discusses his recent study assessing whether there is an increased risk of post-op endophthalmitis in private clinics versus public hospitals.
Vision-threatening uveitis of unknown origin
July 01, 2013
What to investigate: aqueous, vitreous or both?
Point of care tear film test simplifies dry eye management
October 01, 2009
Diagnosing and managing dry eye patients can be challenging. Here Dr Philipp Steven looks at a new way of treating tear film osmolarity, the TearLab Osmolarity System, which he believes could dramatically simplify the process.
Clinical improvement in adenoviral conjunctivitis model
July 15, 2009
Foresight Biotherapeutics, Inc. has announced data from a pre-clinical study designed to assess the safety and efficacy of the topical administration of FST-100 in a highly regarded Ad5 NZW rabbit model of adenoviral conjunctivitis.
Liquid ocular bandage launched in Europe
March 25, 2009
BD OcuSeal Liquid Ocular Bandage, a fully synthetic protective barrier to be used for post-surgical, post-traumatic and non-traumatic ocular conditions, has been launched in Europe by BD Medical?Ophthalmic Systems.
Novagali technologies allow greater drug access to the posterior of the eye
March 25, 2009
According to research analysts it is estimated that as little as five percent of a topically applied drug ever reaches the intraocular tissues due to drug loss as the result of tearing, lacrimal fluid-eye barriers, and blood-ocular barriers.
Retisert implant in sympathetic ophthalmia
March 18, 2009
The fluocinolone acetonide (Retisert; Bausch & Lomb) surgical implant can prevent blindness in cases of sympathetic ophthalmia (SO), according to research at the University of Iowa, US.
Link between skin cancer and eye cancer
March 11, 2009
There is an association between uveal and a variety of skin melanomas, according to study results published in the March issue of Ophthalmology.